XENE Insider Transactions — Page 4
357 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 301–357; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| LAMPERT MARK N | TenPercentOwner | 2017-06-15 | Purchase | 6,774.0 | $3.84 |
| Biotechnology Value Trading Fund OS LP | Other | 2017-06-15 | Purchase | 6,774.0 | $3.84 |
| BVF Partners OS Ltd. | Other | 2017-06-15 | Purchase | 6,774.0 | $3.84 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2017-06-07 | Purchase | 20,594.0 | $3.85 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2017-06-07 | Purchase | 20,594.0 | $3.85 |
| BVF INC/IL | TenPercentOwner | 2017-06-07 | Purchase | 20,594.0 | $3.85 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2017-06-07 | Purchase | 20,594.0 | $3.85 |
| LAMPERT MARK N | TenPercentOwner | 2017-06-07 | Purchase | 20,594.0 | $3.85 |
| Biotechnology Value Trading Fund OS LP | Other | 2017-06-07 | Purchase | 20,594.0 | $3.85 |
| BVF Partners OS Ltd. | Other | 2017-06-07 | Purchase | 20,594.0 | $3.85 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2017-06-07 | Purchase | 73,749.0 | $3.85 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2017-06-07 | Purchase | 73,749.0 | $3.85 |
| BVF INC/IL | TenPercentOwner | 2017-06-07 | Purchase | 73,749.0 | $3.85 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2017-06-07 | Purchase | 73,749.0 | $3.85 |
| LAMPERT MARK N | TenPercentOwner | 2017-06-07 | Purchase | 73,749.0 | $3.85 |
| Biotechnology Value Trading Fund OS LP | Other | 2017-06-07 | Purchase | 73,749.0 | $3.85 |
| BVF Partners OS Ltd. | Other | 2017-06-07 | Purchase | 73,749.0 | $3.85 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2017-06-07 | Purchase | 113,446.0 | $3.85 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2017-06-07 | Purchase | 113,446.0 | $3.85 |
| BVF INC/IL | TenPercentOwner | 2017-06-07 | Purchase | 113,446.0 | $3.85 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2017-06-07 | Purchase | 113,446.0 | $3.85 |
| LAMPERT MARK N | TenPercentOwner | 2017-06-07 | Purchase | 113,446.0 | $3.85 |
| Biotechnology Value Trading Fund OS LP | Other | 2017-06-07 | Purchase | 113,446.0 | $3.85 |
| BVF Partners OS Ltd. | Other | 2017-06-07 | Purchase | 113,446.0 | $3.85 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2017-06-06 | Purchase | 913.0 | $3.75 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2017-06-06 | Purchase | 913.0 | $3.75 |
| BVF INC/IL | TenPercentOwner | 2017-06-06 | Purchase | 913.0 | $3.75 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2017-06-06 | Purchase | 913.0 | $3.75 |
| LAMPERT MARK N | TenPercentOwner | 2017-06-06 | Purchase | 913.0 | $3.75 |
| Biotechnology Value Trading Fund OS LP | Other | 2017-06-06 | Purchase | 913.0 | $3.75 |
| BVF Partners OS Ltd. | Other | 2017-06-06 | Purchase | 913.0 | $3.75 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2017-06-06 | Purchase | 53,260.0 | $3.75 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2017-06-06 | Purchase | 53,260.0 | $3.75 |
| BVF INC/IL | TenPercentOwner | 2017-06-06 | Purchase | 53,260.0 | $3.75 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2017-06-06 | Purchase | 53,260.0 | $3.75 |
| LAMPERT MARK N | TenPercentOwner | 2017-06-06 | Purchase | 53,260.0 | $3.75 |
| Biotechnology Value Trading Fund OS LP | Other | 2017-06-06 | Purchase | 53,260.0 | $3.75 |
| BVF Partners OS Ltd. | Other | 2017-06-06 | Purchase | 53,260.0 | $3.75 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 2017-06-06 | Purchase | 96,736.0 | $3.75 |
| BVF PARTNERS L P/IL | TenPercentOwner | 2017-06-06 | Purchase | 96,736.0 | $3.75 |
| BVF INC/IL | TenPercentOwner | 2017-06-06 | Purchase | 96,736.0 | $3.75 |
| BIOTECHNOLOGY VALUE FUND II LP | Other | 2017-06-06 | Purchase | 96,736.0 | $3.75 |
| LAMPERT MARK N | TenPercentOwner | 2017-06-06 | Purchase | 96,736.0 | $3.75 |
| Biotechnology Value Trading Fund OS LP | Other | 2017-06-06 | Purchase | 96,736.0 | $3.75 |
| BVF Partners OS Ltd. | Other | 2017-06-06 | Purchase | 96,736.0 | $3.75 |
| HOLLER FRANK A | Director | 2016-12-15 | Sale | 30,000.0 | $7.85 |
| HOLLER FRANK A | Director | 2016-08-19 | Sale | 11,938.0 | $7.65 |
| HOLLER FRANK A | Director | 2016-08-18 | Sale | 9,599.0 | $7.7 |
| HOLLER FRANK A | Director | 2016-08-17 | Sale | 1,600.0 | $7.89 |
| HOLLER FRANK A | Director | 2016-08-16 | Sale | 6,863.0 | $8.25 |
| MORTIMER IAN | CFO & COO | 2016-06-24 | Purchase | 1,300.0 | $6.3 |
| MORTIMER IAN | CFO & COO | 2016-06-24 | Purchase | 2,000.0 | $6.25 |
| MORTIMER IAN | CFO & COO | 2016-06-24 | Purchase | 1,000.0 | $6.1 |
| MORTIMER IAN | CFO & COO | 2016-06-24 | Purchase | 1,000.0 | $6.15 |
| GOLDBERG Y. PAUL | VP of Clinical Development | 2015-09-24 | Sale | 12,000.0 | $8.6 |
| GOLDBERG Y. PAUL | VP of Clinical Development | 2015-09-23 | Sale | 4,000.0 | $9.02 |
| GOLDBERG Y. PAUL | VP of Clinical Development | 2015-09-22 | Sale | 6,149.0 | $9.33 |